This is the part I of the article that describes confirmatory adaptive platform trial (CAPT) design for COVID-19 treatment development. In the Introduction, we provide generate description of ACTT, CATCO and SOLIDARITY trials which are emerging as confirmatory trials. We then describe key elements of CAPT design, followed by legal and regulatory requirement for confirmatory trial designs.
Qing Liu, Ph.D., ASA Fellow’s Post
More from this author
-
Systematic Bias in a Randomized Trial of Hydroxychloroquine as Post-exposure Prophylaxis for COVID-19
-
Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment
-
Statistical Considerations for Clinical Trials During COVID-19: Confirmatory Adaptive Platform Trial (CAPT) Design for COVID-19 Treatment (Part III)